BIOLASE, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Lines of Credit and Other Borrowings - Additional Information (Detail)

Lines of Credit and Other Borrowings - Additional Information (Detail) (USD $)	0 Months Ended									12 Months Ended			3 Months Ended
	Nov. 07, 2014	Jul. 28, 2014	Jul. 22, 2014	Jun. 03, 2014	May 31, 2014	May 05, 2014	Apr. 10, 2014	Mar. 04, 2014	Feb. 10, 2014	Dec. 31, 2014 Agreement	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2014	May 24, 2012	Nov. 08, 2013	Sep. 06, 2013
Line Of Credit Facility [Line Items]
Number revolving credit facility agreements										2
Payments under credit agreements		$ 2,900,000us-gaap_RepaymentsOfLinesOfCredit								$ 21,508,000us-gaap_RepaymentsOfLinesOfCredit	$ 32,104,000us-gaap_RepaymentsOfLinesOfCredit	$ 14,963,000us-gaap_RepaymentsOfLinesOfCredit
Credit agreements amendment fee							10,000biol_AmendmentsAndAdministrativeFees	10,000biol_AmendmentsAndAdministrativeFees
Lines of credit maximum borrowing capacity							4,000,000	5,000,000						8,000,000
Line of credit facility, expiration date				Aug. 01, 2014	Aug. 01, 2014	Jun. 01, 2014				May 01, 2014
Revolving lines of credit fee paid				15,000biol_LineOfCreditNonCompliancePayments	10,000biol_LineOfCreditNonCompliancePayments	10,000biol_LineOfCreditNonCompliancePayments
Increase decrease in interest rate of lines of credit facility				0.50%
Outstanding borrowings under lines of credit											4,600,000us-gaap_LineOfCredit
Prime Floor, daily prime plus LIBOR										2.50%biol_PrimeFloor	2.50%biol_PrimeFloor
Unused capacity commitment fee percentage										0.25%	0.25%
Interest expense incurred for lines of credit and loan and security agreement										457,000us-gaap_InterestExpenseBorrowings	599,000us-gaap_InterestExpenseBorrowings
Amortization of deferred debt issuance costs										128,000us-gaap_AmortizationOfFinancingCosts	197,000us-gaap_AmortizationOfFinancingCosts	91,000us-gaap_AmortizationOfFinancingCosts
Amortization of discount on lines of credit										200,000	179,000	43,000
Accrued Interest Payable										0	20,000
Restricted cash amounts										0	0
Additional commitment fees and legal costs incurred										55,000	67,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 4.00
Issuance of stock, net, shares	14,162,873		6,250,000						1,945,525
Financed insurance premium											0biol_FinancedInsurancePremiumPayable	197,000biol_FinancedInsurancePremiumPayable
Number of monthly insurance premium installments payable in 2013										Nine
Interest Expense incurred for financed insurance premiums										3,000us-gaap_InterestExpenseRelatedParty	5,000us-gaap_InterestExpenseRelatedParty	5,000us-gaap_InterestExpenseRelatedParty
Financial insurance premiums interest rate											2.90%
Domestic Revolver Credit Facility
Line Of Credit Facility [Line Items]
Lines of credit maximum borrowing capacity														4,000,000
Outstanding borrowings under lines of credit											1,800,000
Domestic Revolver Credit Facility \| Prime Rate
Line Of Credit Facility [Line Items]
Interest on principal balance rate plus										2.50%	2.00%
Ex-Im Revolver
Line Of Credit Facility [Line Items]
Lines of credit maximum borrowing capacity														4,000,000
Outstanding borrowings under lines of credit											2,800,000
Ex-Im Revolver \| Prime Rate
Line Of Credit Facility [Line Items]
Interest on principal balance rate plus										2.00%	1.50%
November 2013 Comerica Warrant
Line Of Credit Facility [Line Items]
Warrants issued to purchase common stock															100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights															$ 2.00
Expiration date of warrant shares if unexercised											Nov. 08, 2018
Fair value warrants expected term											5 years
Fair value warrants volatility rate											102.65%
Fair value warrants dividend per share											$ 0.00
Fair value warrants risk free interest rate											1.42%
Fair value of warrants											137,000
Number of Comerica Bank warrants exercised													100,000
Issuance of stock, net, shares													19,354
September 2013 Comerica Warrant
Line Of Credit Facility [Line Items]
Warrants issued to purchase common stock																100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights																$ 2.00
Fair value warrants expected term											5 years
Fair value warrants volatility rate											105.32%
Fair value warrants dividend per share											$ 0.00
Fair value warrants risk free interest rate											1.77%
Fair value of warrants											143,000
Number of Comerica Bank warrants exercised													100,000
Issuance of stock, net, shares													19,354
2012 Comerica Warrant
Line Of Credit Facility [Line Items]
Warrants issued to purchase common stock												80,000
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 2.83
Expiration date of warrant shares if unexercised												May 24, 2017
Fair value of warrants												$ 142,000
Number of Comerica Bank warrants exercised												80,000
Reduced exercise price of warrants												$ 2.00
Net issuance of common stock due to exercise of warrants												40,465